Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002313658 | SCV000848859 | likely benign | Inborn genetic diseases | 2016-09-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000874717 | SCV001016934 | benign | KBG syndrome | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001707852 | SCV001935149 | benign | not provided | 2019-12-27 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000874717 | SCV002524200 | benign | KBG syndrome | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001707852 | SCV004143508 | benign | not provided | 2022-05-01 | criteria provided, single submitter | clinical testing | ANKRD11: BS1, BS2 |
Prevention |
RCV003928202 | SCV004744380 | likely benign | ANKRD11-related disorder | 2023-01-18 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |